US Stock MarketDetailed Quotes

Xilio Therapeutics (XLO)

Watchlist
  • 0.6503
  • +0.0003+0.05%
Close Dec 30 16:00 ET
34.14MMarket Cap-1.07P/E (TTM)

Xilio Therapeutics (XLO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
742.51%19.07M
242.98%8.08M
2.93M
6.34M
1.72M
2.26M
2.36M
0
0
0
Operating revenue
742.51%19.07M
242.98%8.08M
--2.93M
--6.34M
--1.72M
--2.26M
--2.36M
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
23.02%21M
31.82%22.45M
1.46%16.78M
-16.61%65.99M
-15.32%15.35M
-1.70%17.07M
-15.34%17.03M
-29.70%16.54M
-11.24%79.13M
-21.74%18.13M
Selling and administrative expenses
5.82%6.67M
22.44%7.12M
38.70%8.52M
-8.22%24.78M
1.92%6.52M
-0.05%6.31M
-15.70%5.82M
-16.98%6.14M
-9.85%27M
-21.74%6.39M
-General and administrative expense
5.82%6.67M
22.44%7.12M
38.70%8.52M
-8.22%24.78M
1.92%6.52M
-0.05%6.31M
-15.70%5.82M
-16.98%6.14M
-9.85%27M
-21.74%6.39M
Research and development costs
33.11%14.32M
36.68%15.33M
-20.52%8.27M
-20.95%41.21M
-24.71%8.84M
-2.64%10.76M
-15.15%11.22M
-35.53%10.4M
-11.93%52.14M
-21.74%11.74M
Operating profit
86.97%-1.93M
2.10%-14.37M
16.25%-13.85M
24.63%-59.65M
24.83%-13.63M
14.73%-14.8M
27.05%-14.67M
29.70%-16.54M
11.24%-79.13M
21.74%-18.13M
Net non-operating interest income expense
Other net income (expense)
-1,933.72%-14.36M
-297.33%-1.48M
188.25%586K
-48.55%1.4M
12.84%536K
27.73%783K
-1.58%749K
-175.45%-664K
194.39%2.73M
-32.24%475K
Gain on sale of security
---15.38M
---50K
----
----
----
----
----
----
----
----
Special income (charges)
--0
--0
--0
---937K
--0
--41K
---30K
---948K
--0
--0
-Less:Restructuring and merger&acquisition
--0
--0
--0
--937K
--0
---41K
--30K
--948K
--0
--0
Other non- operating income (expenses)
37.74%1.02M
-283.31%-1.43M
106.34%586K
-14.22%2.34M
12.84%536K
21.04%742K
2.37%779K
-67.73%284K
194.39%2.73M
-32.24%475K
Income before tax
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
23.77%-58.24M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.2M
13.40%-76.4M
21.41%-17.66M
Income tax
Net income
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
23.77%-58.24M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.2M
13.40%-76.4M
21.41%-17.66M
Net income continuous Operations
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
23.77%-58.24M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.2M
13.40%-76.4M
21.41%-17.66M
Minority interest income
Net income attributable to the parent company
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
23.77%-58.24M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.2M
13.40%-76.4M
21.41%-17.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-16.17%-16.29M
-13.78%-15.84M
22.89%-13.27M
23.77%-58.24M
25.84%-13.09M
16.29%-14.02M
28.05%-13.93M
24.04%-17.2M
13.40%-76.4M
21.41%-17.66M
Basic earnings per share
50.00%-0.11
33.33%-0.16
70.97%-0.18
60.79%-1.09
68.75%-0.2
63.93%-0.22
65.71%-0.24
25.30%-0.62
13.66%-2.78
21.95%-0.64
Diluted earnings per share
50.00%-0.11
33.33%-0.16
70.97%-0.18
60.79%-1.09
68.75%-0.2
63.93%-0.22
65.71%-0.24
25.30%-0.62
13.66%-2.78
21.95%-0.64
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 742.51%19.07M242.98%8.08M2.93M6.34M1.72M2.26M2.36M000
Operating revenue 742.51%19.07M242.98%8.08M--2.93M--6.34M--1.72M--2.26M--2.36M--0--0--0
Cost of revenue
Gross profit
Operating expense 23.02%21M31.82%22.45M1.46%16.78M-16.61%65.99M-15.32%15.35M-1.70%17.07M-15.34%17.03M-29.70%16.54M-11.24%79.13M-21.74%18.13M
Selling and administrative expenses 5.82%6.67M22.44%7.12M38.70%8.52M-8.22%24.78M1.92%6.52M-0.05%6.31M-15.70%5.82M-16.98%6.14M-9.85%27M-21.74%6.39M
-General and administrative expense 5.82%6.67M22.44%7.12M38.70%8.52M-8.22%24.78M1.92%6.52M-0.05%6.31M-15.70%5.82M-16.98%6.14M-9.85%27M-21.74%6.39M
Research and development costs 33.11%14.32M36.68%15.33M-20.52%8.27M-20.95%41.21M-24.71%8.84M-2.64%10.76M-15.15%11.22M-35.53%10.4M-11.93%52.14M-21.74%11.74M
Operating profit 86.97%-1.93M2.10%-14.37M16.25%-13.85M24.63%-59.65M24.83%-13.63M14.73%-14.8M27.05%-14.67M29.70%-16.54M11.24%-79.13M21.74%-18.13M
Net non-operating interest income expense
Other net income (expense) -1,933.72%-14.36M-297.33%-1.48M188.25%586K-48.55%1.4M12.84%536K27.73%783K-1.58%749K-175.45%-664K194.39%2.73M-32.24%475K
Gain on sale of security ---15.38M---50K--------------------------------
Special income (charges) --0--0--0---937K--0--41K---30K---948K--0--0
-Less:Restructuring and merger&acquisition --0--0--0--937K--0---41K--30K--948K--0--0
Other non- operating income (expenses) 37.74%1.02M-283.31%-1.43M106.34%586K-14.22%2.34M12.84%536K21.04%742K2.37%779K-67.73%284K194.39%2.73M-32.24%475K
Income before tax -16.17%-16.29M-13.78%-15.84M22.89%-13.27M23.77%-58.24M25.84%-13.09M16.29%-14.02M28.05%-13.93M24.04%-17.2M13.40%-76.4M21.41%-17.66M
Income tax
Net income -16.17%-16.29M-13.78%-15.84M22.89%-13.27M23.77%-58.24M25.84%-13.09M16.29%-14.02M28.05%-13.93M24.04%-17.2M13.40%-76.4M21.41%-17.66M
Net income continuous Operations -16.17%-16.29M-13.78%-15.84M22.89%-13.27M23.77%-58.24M25.84%-13.09M16.29%-14.02M28.05%-13.93M24.04%-17.2M13.40%-76.4M21.41%-17.66M
Minority interest income
Net income attributable to the parent company -16.17%-16.29M-13.78%-15.84M22.89%-13.27M23.77%-58.24M25.84%-13.09M16.29%-14.02M28.05%-13.93M24.04%-17.2M13.40%-76.4M21.41%-17.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -16.17%-16.29M-13.78%-15.84M22.89%-13.27M23.77%-58.24M25.84%-13.09M16.29%-14.02M28.05%-13.93M24.04%-17.2M13.40%-76.4M21.41%-17.66M
Basic earnings per share 50.00%-0.1133.33%-0.1670.97%-0.1860.79%-1.0968.75%-0.263.93%-0.2265.71%-0.2425.30%-0.6213.66%-2.7821.95%-0.64
Diluted earnings per share 50.00%-0.1133.33%-0.1670.97%-0.1860.79%-1.0968.75%-0.263.93%-0.2265.71%-0.2425.30%-0.6213.66%-2.7821.95%-0.64
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More